Susquehanna International Group’s Procept Biorobotics PRCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.21M Sell
88,200
-28,200
-24% -$795K ﹤0.01% 5954
2025
Q4
$3.66M Buy
116,400
+3,200
+3% +$106K ﹤0.01% 4542
2025
Q3
$4.04M Buy
113,200
+86,400
+322% +$3.95M ﹤0.01% 4456
2025
Q2
$1.54M Sell
26,800
-42,500
-61% -$2.4M ﹤0.01% 6371
2025
Q1
$4.04M Buy
69,300
+12,100
+21% +$826K ﹤0.01% 4060
2024
Q4
$4.61M Sell
57,200
-18,200
-24% -$1.55M ﹤0.01% 3727
2024
Q3
$6.04M Buy
75,400
+7,000
+10% +$497K ﹤0.01% 3294
2024
Q2
$4.18M Sell
68,400
-83,600
-55% -$4.97M ﹤0.01% 3738
2024
Q1
$7.51M Buy
152,000
+65,500
+76% +$3.12M ﹤0.01% 3024
2023
Q4
$3.63M Buy
86,500
+33,600
+64% +$1.14M ﹤0.01% 4268
2023
Q3
$1.74M Buy
52,900
+43,200
+445% +$1.47M ﹤0.01% 5426
2023
Q2
$343K Sell
9,700
-187,800
-95% -$6.21M ﹤0.01% 9170
2023
Q1
$5.61M Buy
197,500
+89,200
+82% +$3.15M ﹤0.01% 3290
2022
Q4
$4.5M Buy
108,300
+2,600
+2% +$112K ﹤0.01% 3399
2022
Q3
$4.38M Buy
105,700
+7,500
+8% +$299K ﹤0.01% 3383
2022
Q2
$3.21M Buy
+98,200
New +$3.57M ﹤0.01% 3947

Other funds holding PRCT

Susquehanna International Group's PRCT Position: Q1 2026 in Review

Susquehanna International Group reduced its Procept Biorobotics (PRCT) stake by 20% in Q1 2026, selling an estimated $237K and leaving 33,101 shares worth $828K. The position accounts for ﹤0.01% of the portfolio, ranked #8392.

Susquehanna International Group first reported a position in PRCT in Q3 2021 and has held it in 15 quarters since. The position peaked at $3.62M in Q2 2025. 256 funds tracked by Wall St. Rank hold PRCT as of Q1 2026.

  • Susquehanna International Group held 33,101 shares of Procept Biorobotics worth $828K as of Q1 2026.
  • Susquehanna International Group sold 8,404 Procept Biorobotics shares in Q1 2026, an estimated $237K.
  • Procept Biorobotics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #8392 holding.
  • Susquehanna International Group first reported a position in Procept Biorobotics in Q3 2021 and has held it in 15 quarters since.
  • Susquehanna International Group's Procept Biorobotics position peaked at $3.62M in Q2 2025.
  • 256 funds tracked by Wall St. Rank held Procept Biorobotics as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.